Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics SL

Artizan Biosciences, Inc. announced that it has entered into a multi-year research collaboration with the University Medical Center Utrecht in The Netherlands and Microviable Therapeutics SL to explore the role that gut microbiota may have in immune checkpoint inhibitor therapies for patients with cancer.